<DOC>
	<DOCNO>NCT01684475</DOCNO>
	<brief_summary>The purpose study assess ability CJH1 increase sensitivity dopamine receptor thereby reduce symptom Parkinson 's Disease .</brief_summary>
	<brief_title>A STUDY TO EVALUATE THE EFFICACY OF CJH1 ( CLR4001 ) IN PARKINSON 'S DISEASE</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Patient 's Parkinson 's disease Contraindications study medication</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Novel Treatment Parkinson 's disease</keyword>
</DOC>